Related Experiment Video
Updated: Sep 29, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HIV-1 Drug Resistance in Mother-Infant Pairs in Southern Mozambique
David Torres-Fernandez1,2,3, Sheila Fernández-Luis1,2,4, Sara Domínguez-Rodríguez4,5,6
1From the ISGlobal, Barcelona, Spain.
Abstract:
This prospective nested cohort (EARTH) study evaluated drug resistance mutations and outcomes among 79 (31 with genetic results) early-treated Mozambican children living with HIV, followed for 50 months. Mortality reached 20.3%. Drug resistance mutations were detected in 58.1% of children and 50.0% of mothers; 30% of pairs shared mutations. No integrase inhibitor resistance was detected, supporting Mozambique's transition to dolutegravir-based regimens.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors